Literature DB >> 33987225

Mitochondrial dysfunction attenuates rapid regeneration in livers with toxin-induced fibrosis.

Zheyong Li1,2, Yuelong Liang1,2, Hanning Ying1,2, Mingyu Chen1,2, Xiaoyan He2,3, Yifan Wang1,2, Yifan Tong1,2, Xiujun Cai1,2.   

Abstract

BACKGROUND: The mechanism of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)-induced rapid liver regeneration remains poorly documented, especially in patients with fibrosis. Therefore, this study aims to investigate the underlying mechanism of ALPPS-induced accelerated regeneration in toxin-induced fibrosis models.
METHODS: The ALPPS-induced regeneration model was established in livers with thioacetamide (TAA)-induced fibrosis to determine the regenerative pathways involved in rapid regeneration. Confirmatory experiments were performed in transforming growth factor beta 1 (TGFβ1)-treated AML12 cells and mice with carbon tetrachloride (CCl4)-induced fibrosis. Finally, mitochondrial dysfunction was validated in fibrotic/non-fibrotic patients.
RESULTS: In TAA-induced fibrotic mice, ALPPS-induced regeneration was significantly inferior to that of the control group (P=0.027 at day 2 and P<0.001 at day 7). Furthermore, mitochondria-associated genes were significantly downregulated in TAA-challenged mice. Accordingly, the reduced production of ATP and elevated levels of malondialdehyde indicated disturbances in intracellular energy metabolism during the ALPPS-induced regenerative process after TAA treatment. Further investigations were performed in TGF-β1-treated AML12 cells and CCl4-treated mice, which indicated that mitochondrial dysfunction attenuated the capacity for rapid regeneration after ALPPS.
CONCLUSIONS: In summary, this study revealed that mitochondrial dysfunction led to inferior regeneration in livers with toxin-induced fibrosis and identified new therapeutic targets to improve the feasibility and safety of the ALPPS procedure. Further studies in human patients are required in the future. 2021 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS); fibrosis; mitochondrial dysfunction; regeneration

Year:  2021        PMID: 33987225      PMCID: PMC8105818          DOI: 10.21037/atm-20-4639

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  27 in total

1.  Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells.

Authors:  Kengo Tomita; Toshiaki Teratani; Takahiro Suzuki; Motonori Shimizu; Hirokazu Sato; Kazuyuki Narimatsu; Shingo Usui; Hirotaka Furuhashi; Akifumi Kimura; Kiyoshi Nishiyama; Tadashi Maejima; Yoshikiyo Okada; Chie Kurihara; Katsuyoshi Shimamura; Hirotoshi Ebinuma; Hidetsugu Saito; Hirokazu Yokoyama; Chikako Watanabe; Shunsuke Komoto; Shigeaki Nagao; Kazuo Sugiyama; Suefumi Aosasa; Kazuo Hatsuse; Junji Yamamoto; Toshifumi Hibi; Soichiro Miura; Ryota Hokari; Takanori Kanai
Journal:  J Hepatol       Date:  2014-03-18       Impact factor: 25.083

Review 2.  The HPB controversy of the decade: 2007-2017 - Ten years of ALPPS.

Authors:  Pim B Olthof; Andreas A Schnitzbauer; Erik Schadde
Journal:  Eur J Surg Oncol       Date:  2018-06-18       Impact factor: 4.424

3.  JNK1 induces hedgehog signaling from stellate cells to accelerate liver regeneration in mice.

Authors:  Magda Langiewicz; Rolf Graf; Bostjan Humar; Pierre A Clavien
Journal:  J Hepatol       Date:  2018-04-28       Impact factor: 25.083

Review 4.  Repairing Mitochondrial Dysfunction in Disease.

Authors:  Vincenzo Sorrentino; Keir J Menzies; Johan Auwerx
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-09-27       Impact factor: 13.820

5.  Hedgehog pathway mediates early acceleration of liver regeneration induced by a novel two-staged hepatectomy in mice.

Authors:  Magda Langiewicz; Andrea Schlegel; Enrica Saponara; Michael Linecker; Pieter Borger; Rolf Graf; Bostjan Humar; Pierre A Clavien
Journal:  J Hepatol       Date:  2016-10-19       Impact factor: 25.083

6.  Mitochondrial function after associating liver partition and portal vein ligation for staged hepatectomy in an experimental model.

Authors:  A Budai; G Horváth; L Tretter; Z Radák; E Koltai; Z Bori; F Torma; Á Lukáts; P Röhlich; A Szijártó; A Fülöp
Journal:  Br J Surg       Date:  2018-09-27       Impact factor: 6.939

7.  Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.

Authors:  Tatiana Kisseleva; Min Cong; Yonghan Paik; David Scholten; Chunyan Jiang; Chris Benner; Keiko Iwaisako; Thomas Moore-Morris; Brian Scott; Hidekazu Tsukamoto; Sylvia M Evans; Wolfgang Dillmann; Christopher K Glass; David A Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

8.  Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients.

Authors:  Zheng Wang; Yuanfei Peng; Jingwu Hu; Xiaoying Wang; Huichuan Sun; Jian Sun; Yinghong Shi; Yongsheng Xiao; Zhenbing Ding; Xinrong Yang; Min Tang; Zhaoyou Tang; Jiping Wang; Wan Y Lau; Jia Fan; Jian Zhou
Journal:  Ann Surg       Date:  2020-03       Impact factor: 12.969

9.  Role of Kupffer cells in the progression of CRC liver metastases after the first stage of ALPPS.

Authors:  Rocio García-Pérez; Joana Ferrer Fábrega; Aranzazu Varona-Bosque; Carlos Manuel Martínez; Beatriz Revilla-Nuin; Laia Cabellos; Romina Pena; Ramón Vilana; Carolina Gonzalez-Abós; Juan Carlos García-Valdecasas; José Fuster Obregón
Journal:  Sci Rep       Date:  2018-05-24       Impact factor: 4.379

Review 10.  Mitochondrial Dysfunction in Aging and Cancer.

Authors:  Loredana Moro
Journal:  J Clin Med       Date:  2019-11-15       Impact factor: 4.241

View more
  1 in total

1.  The effect of Cyclophilin D depletion on liver regeneration following associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Noemi Daradics; Gergo Horvath; Laszlo Tretter; Agnes Paal; Andras Fulop; Andras Budai; Attila Szijarto
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.